•
Dec 31, 2022

Cocrystal Pharma Q4 2022 Earnings Report

EPS
-$0.54
Previous year: -$0.48
+12.5%
Cash and Equivalents
$37.1M
Previous year: $58.7M
-36.7%
Free Cash Flow
-$4.91M
Previous year: -$2.93M
+67.4%
Total Assets
$40.8M
Previous year: $79.4M
-48.6%

Cocrystal Pharma

Cocrystal Pharma